ICAD Inc
NASDAQ:ICAD

Watchlist Manager
ICAD Inc Logo
ICAD Inc
NASDAQ:ICAD
Watchlist
Price: 1.685 USD -7.92% Market Closed
Market Cap: 44.7m USD
Have any thoughts about
ICAD Inc?
Write Note

Gross Margin
ICAD Inc

86%
Current
79%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
86%
=
Gross Profit
16.3m
/
Revenue
18.9m

Gross Margin Across Competitors

Country US
Market Cap 44.4m USD
Gross Margin
86%
Country US
Market Cap 36.5B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.1B AUD
Gross Margin
100%
Country US
Market Cap 10.9B USD
Gross Margin
90%
Country US
Market Cap 6.4B USD
Gross Margin
67%
Country JP
Market Cap 934B JPY
Gross Margin
58%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 53.2B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.2B CNY
Gross Margin
43%
No Stocks Found

ICAD Inc
Glance View

Market Cap
44.4m USD
Industry
Health Care

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

ICAD Intrinsic Value
1.674 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
86%
=
Gross Profit
16.3m
/
Revenue
18.9m
What is the Gross Margin of ICAD Inc?

Based on ICAD Inc's most recent financial statements, the company has Gross Margin of 86%.